TT

Travere Therapeutics

TVTX
NASDAQHealth Care

Income Statement

Total Revenue$233.18M
Gross Profit$225.43M
Operating Income$-323.83M
EBITDA$-266.69M
EBIT$-310.24M
Pre-tax Income$-44.81M
Net Income$-321.55M

Balance Sheet

Cash Equivalent$42.62M
Total Debt$402.82M
Book Value$29.46M
Book Value Per Share0.38

Key Ratios

Return on Equity (ROE)-544.28%
Return on Assets (ROA)-54.12%
Return on Invested Capital (ROI)-73.40%
Net Profit Margin-137.90%
Current Ratio2.08
Quick Ratio1.98
Long-Term Debt / Equity5.25